GENEVA, SWITZERLAND / ACCESSWIRE / January 19, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the…
LAS VEGAS, NV / ACCESSWIRE / January 5, 2022 / UMAX Group Corp. (OTC PINK:UMAX), a Nevada corporation, would like to announce that it has filed amended articles of incorporation with the State of Nevada,…
GENEVA, SWITZERLAND / ACCESSWIRE / January 6, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (“ Relief “), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need,…
VANCOUVER, BC / ACCESSWIRE / December 24, 2021 / Skeena Resources Limited (TSX:SKE)(NYSE:SKE) (“Skeena” or the “Company”) is pleased to announce that, on December 23, 2021, it closed the structured non-brokered private placement offering (the…
GENEVA, SWITZERLAND / ACCESSWIRE / December 30, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the…
GENEVA, SWITZERLAND / ACCESSWIRE / November 29, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTC PINK:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that…
LOS ANGELES, CA / ACCESSWIRE / November 30, 2021 / Even though they are relatively new, NFTs are extremely popular, and every day, the popularity increases not only because the various blockchains represent DeFi (decentralized…
ATLANTA, GA / ACCESSWIRE / November 18, 2021 / COVID-19 testing is a relatively straightforward process that tends to only take a few minutes to complete. However, getting tested for COVID-19 can certainly be a…
GREENWOOD VILLAGE, CO / ACCESSWIRE / November 11, 2021 / SPYR, Inc. dba SPYR Technologies (OTCQB:SPYR), a technology company whose subsidiary Applied Magix, Inc. develops and resells Apple® ecosystem compatible products in the growing multi-billion-dollar…
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 20, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the first patient has been dosed in the Phase 2 IGNAZ clinical trial evaluating felzartamab for patients with Immunoglobulin A…